Amy Wakeham | VP, IR & Corporate Communications |
Mick Farrell | CEO |
Brett Sandercock | CFO |
Rob Douglas | President and COO |
Jim Hollingshead | President, Sleep & Respiratory Care business |
David Pendarvis | Chief Administrative Officer and Global General Counsel |
Chris Cooper | Goldman Sachs |
Dan Hurren | MST Marquee |
Sean Laaman | Morgan Stanley |
Matthew Mishan | KeyBanc |
Craig Wong-Pan | Royal Bank of Canada |
Andrew Paine | CLSA |
John Deakin-Bell | Citigroup |
Gretel Janu | Credit Suisse |
Saul Hadassin | Barrenjoey Capital |
Lyanne Harrison | Bank of America |
Steve Wheen | Jarden Australia |
David Bailey | Macquarie |
Margaret Kaczor | William Blair |
Suraj Kalia | Oppenheimer |
Michael Polark | Baird |
Mike Matson | Needham & Company |
Hello and welcome to the ResMed Second Quarter Fiscal Year 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It's my pleasure to turn the call over to Amy Wakeham, Vice President-Investor Relations and Corporate Communications.